The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
NCT00275639 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2012-01-06
Summary
This research study is being done to study the effects, both good and bad, of calcineurin inhibitors and the drug Cozaar (losartan), on kidney function and kidney scarring following a liver transplant.
Conditions
- Liver Transplant Recipients
Interventions
- DRUG
-
Cozaar
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
K.V. Narayanan Menon, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
- Primary Completion
- 2007-08-31
- Completion
- 2007-08-31
Countries
- United States
Study Locations
More Related Trials
-
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
NCT01560572 ·Status: COMPLETED ·Phase: PHASE4
-
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
NCT00541814 ·Status: UNKNOWN ·Phase: PHASE4
-
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
NCT00135694 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
NCT01230502 ·Status: TERMINATED ·Phase: NA
-
Reduced-dose Alemtuzumab for Kidney Transplant Rejection
NCT06100965 ·Status: RECRUITING
-
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
NCT00890253 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
NCT00956293 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
NCT00284947 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
NCT00295594 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension
NCT03781414 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
NCT01011205 ·Status: COMPLETED ·Phase: PHASE3
-
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
NCT00658320 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant
NCT00099736 ·Status: COMPLETED ·Phase: PHASE3
-
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
NCT04258423 ·Status: TERMINATED ·Phase: PHASE3
-
Belatacept in Liver Transplant Recipients
NCT00555321 ·Status: TERMINATED ·Phase: PHASE2
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
NCT06280950 ·Status: RECRUITING ·Phase: PHASE2
-
Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants
NCT03605654 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
NCT07219043 ·Status: RECRUITING ·Phase: PHASE2
-
Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
NCT00239811 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients
NCT00213590 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.
NCT02040584 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
NCT00622869 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
NCT03221842 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
NCT00758602 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
NCT02564497 ·Status: COMPLETED ·Phase: PHASE1